RNS Number : 3011G
EKF Diagnostics Holdings PLC
28 June 2012
 



EKF Diagnostics Holdings plc

("EKF" or the "Company")

 

Director's Share Options

 

EKF Diagnostics Holdings plc (AIM: EKF), the growing in-vitro diagnostics company, announces that the Company has agreed to a 6 month extension of the exercise period relating to share options over 500,000 Ordinary Shares previously granted to Gordon Hall, Non-Executive Director of the Company, in 2005.

The latest date for the exercise of these options has been extended by 6 months from 28 June 2012 to 28 December 2012. The exercise price remains unchanged at 20 pence per Ordinary Share.

 

Enquiries:

 

EKF Diagnostics Holdings plc     

Tel: 029 2071 0570

David Evans, Executive Chairman


Julian Baines, CEO                                        




Canaccord Genuity Limited

Tel: 020 7523 8000

Jamie Adams / Mark Dickenson / Lucy Tilley




Walbrook PR Limited 

Tel: 020 7933 8780

Paul McManus

Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com



 

 

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFIRRAIDFIF
admin Director's Share Options 20191543 A Thu, 06/28/2012 - 07:00 Directors' Dealings EKF